Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery
NCT03231813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2017-10-02
Summary
Irritant contact dermatitis induced by sodium lauryl sulphate (SLS) is often used as a model for testing efficacy of various topical preparations. Aforementioned model is standardized and described in guidelines, but it is not explicitly stated where the irritation should be induced. Published clinical trials usually irritate volar aspect of forearms or upper back. Also, lower back and dorsal aspect of forearm are sometimes used.
Skin parameters vary depending on anatomic location of measured skin. There is a difference in stratum corneum thickness, hydration and transepidermal water loss across different locations, including between volar forearm and upper back.
Furthermore, regional difference in skin response to irritation by tape stripping and benzalkonium chloride were observed. Such differences are also possible in SLS irritation model. One study has shown higher, but not statistically significant, response of back in comparison to forearms, but it had a very small sample size (n=9).
Moreover, there are regional variations of topical preparations absorption. Hydrocortisone had 1,7 times higher absorption when applied to upper back in comparison to forearms. Those variations could be explained by different corneocyte size and number of their layers between back and hands.
Skin baseline properties and response to irritation seem to be dependent on anatomic position. Those differences could mean different response to treatment. Since published trials only tested efficacy of various preparations on one anatomic location, it is possible their results would be different if tested on other body parts. It could limit validity and usefulness of conducted trials. The aim of this study is to determine if there are regional differences of skin response to irritation and emollient cream treatment in irritant contact dermatitis model.
Conditions
- Irritant Contact Dermatitis
Interventions
- PROCEDURE
-
Sodium lauryl sulphate induced irritation
Sodium lauryl sulphate will be applied to specified skin sites according to randomization protocol to induce irritation. 60 uL of 2% w/v SLS will be applied to skin under occlusion by large Finn chamber for 24 hours as described in the guidelines by Standardization group of European Society of Contact Dermatitis.
- OTHER
-
Emollient, moisturizing cream
Commercially available topical emollient cream will be applied by each participant to treatment sites according to randomization protocol.
Sponsors & Collaborators
-
University of Split, School of Medicine
lead OTHER
Principal Investigators
-
Dario Leskur, MPharm · University of Split, School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-29
- Primary Completion
- 2017-09-28
- Completion
- 2017-09-28
Countries
- Croatia
Study Locations
More Related Trials
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
NCT01892657 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Cicaplast in Subjects With Skin Irritation
NCT05767333 ·Status: COMPLETED
-
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT02419248 ·Status: COMPLETED
-
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671 ·Status: RECRUITING ·Phase: NA
-
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
NCT01892423 ·Status: COMPLETED ·Phase: NA
-
Assessment of Skin Barrier Disruption Due to Daily Use of Cleaning Products and Hand Disinfectants
NCT06269315 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50
NCT01887860 ·Status: COMPLETED ·Phase: NA
-
Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities
NCT04929834 ·Status: UNKNOWN ·Phase: NA
-
Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin
NCT03093597 ·Status: COMPLETED ·Phase: NA
-
Moisturizing Effect of Two Dexpanthenol Formulations
NCT00839280 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Safety Study of Topical Diltiazem Hydrochloride
NCT01816529 ·Status: UNKNOWN ·Phase: PHASE1
-
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30
NCT01887808 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers
NCT03301870 ·Status: COMPLETED ·Phase: PHASE1
-
Epidemiology and Co-Reactivity of Novel Surfactant Allergens
NCT02534441 ·Status: COMPLETED ·Phase: NA
-
Cumulative Irritation Test of PAC-14028 in Healthy Volunteers
NCT01638117 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser
NCT01888887 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Dexpanthenol in Thermic Erythema
NCT00839462 ·Status: COMPLETED ·Phase: PHASE2
-
Skin Irritation Test of Ten Products
NCT05245383 ·Status: UNKNOWN ·Phase: NA
-
Contact Allergy to Rubber Accelerators - a Clinical Study
NCT06042309 ·Status: COMPLETED ·Phase: NA
-
Hand Sanitizer Effects on the Skin Barrier
NCT04525521 ·Status: UNKNOWN
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin
NCT02338076 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA